Filing Flows › RXO (RXO) › Takeover & LBO
Is RXO (RXO) a takeover target?
A leveraged buyout does not work for RXO on its latest figures: its EBITDA margin is only 0.9% ($56.0M on revenue of $6.5B), too thin to carry buyout debt. Historically 3.7% of companies with its figures were bought within a year (0.73× the average). Latest signal (2026-10-05): Agreed sale to Company at $17.25 cash a share · pending.
Why a leveraged buyout does not fit
RXO kept 0.9% of its revenue as EBITDA over the last 12 months ($56.0M on $6.5B). A margin that thin cannot carry the debt a leveraged buyout needs — a small dip in sales would leave nothing for interest — so the model gives no buyout price.
What a takeover could cost
Takeovers in its sector paid a median premium of 40% over the share price before the deal (the middle half 14.7% to 60.2%), according to the 20 merger proxies and tender-offer responses on EDGAR that state a premium. At the median, RXO would cost about $38.66 a share, $6.6B for all its shares.
| Premium | % | Price a share | All shares |
|---|---|---|---|
| Low end (a quarter of deals paid less) | 14.7% | $31.67 | $5.4B |
| Median | 40% | $38.66 | $6.6B |
| High end (a quarter paid more) | 60.2% | $44.24 | $7.6B |
The odds, from history
Historically 3.7% of companies with its figures were bought within a year (0.73× the average). Its figures put it in decile 3 of 10 (10 = the most likely to be bought). The odds come from a model of every merger proxy, tender-offer response and going-private statement filed on EDGAR since 2011, set against each company's size, margins, debt, cash flow and growth the year before.
Rumors and deal signals
- 2026-10-05 · deal · Agreed sale to Company at $17.25 cash a share · pending
RXO's latest quarter
RXO, Q3 2026: revenue $1.9B (+32% year over year), operating margin 0.9%, net earnings $3.0M, operating cash flow $25.0M. The chart follows the revenue to costs, profit and cash.
Questions
Is RXO being acquired?
The latest signal on file is from 2026-10-05: Agreed sale to Company at $17.25 cash a share · pending. A headline is not a deal; Filing Flows lists the news, 8-K filings and 13D filings about a sale.
Could private equity buy RXO?
A leveraged buyout does not work for RXO on its latest figures: its EBITDA margin is only 0.9% ($56.0M on revenue of $6.5B), too thin to carry buyout debt. A margin that thin leaves almost nothing to pay interest with, so buyout debt does not fit.
What would a takeover of RXO cost?
Takeovers in its sector paid a median premium of 40% over the share price before the deal (the middle half 14.7% to 60.2%), according to the 20 merger proxies and tender-offer responses on EDGAR that state a premium. At the median, RXO would cost about $38.66 a share, $6.6B for all its shares.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.